Supriya Lifescience Limited has announced that the Hon’ble Supreme Court has admitted a judicial proceeding related to the company. In an interim order, the Court has directed that no coercive action will be taken against the Directors, officers, or officials of the petitioner, subject to specified terms. The matter is currently sub judice, and the company will provide further updates on any material developments.
Supreme Court Admits Judicial Proceedings
Supriya Lifescience Limited informed the stock exchanges that the Hon’ble Supreme Court has admitted a significant judicial proceeding concerning the company. This intimation is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and follows previous disclosures on the matter.
Interim Relief Granted
In a crucial interim directive, the Hon’ble Supreme Court has ordered that no coercive action shall be taken against the Directors, officers, or officials of the petitioner. This relief is granted subject to the fulfillment of the terms and conditions stipulated in the order passed by the Court.
Status and Future Updates
The matter is presently pending before the Hon’ble Court and is considered sub judice. Supriya Lifescience Limited will continue to actively monitor the proceedings. The company commits to keeping the Stock Exchanges and its shareholders informed of any material developments as they are received from the Hon’ble Court or as required by applicable laws and regulations.
Source: BSE
